GA-FARM-TO-PLATE
Today, Farm to Plate announced the immediate availability of Farm To Plate (F2P), a pioneering blockchain-based provenance and tracking product for the Food supply chain that will expand the scope of data transparency to the grassroots of the food industry – end-to-end, from the producers to the consumers. The Farm to Plate platform addresses increased regulatory demands for digitization and transparency through GS1 and FDA FSMA Rule #204 compliance and heightens brand trust, financial stability, and reputation by enabling a focus on sustainability, responsible farming, consumer transparency, and significantly reduced recall risk and size. See how it works.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230228006317/en/
Key Features and Benefits of Farm to Plate
- Microtipping: Enables direct tips to producers from end consumers that are securely, instantaneously transmitted over the blockchain, eliminating middlemen and chances of fraud while giving producers a great boost to their meager revenues.
- Immutable, end-to-end tracking and trace: Immutable, decentralized information ensures no single stakeholder has disproportionate information ownership, eliminating the risk of data fudging.
- Secure access control for information on the blockchain: Strong access controls enable granular control over who has access to what data, ensuring only relevant, required information is accessible to different parties.
- Built on GS1 standards and compliant with FDA FSMA Rule #204.
Fulfilling Consumers’ Need for End-to-end Transparency
In a globalized food supply chain where food is sourced and transported across continents, the level of transparency, from sourcing, transportation, to storage and other details, that consumers are now demanding is unprecedented. Research also proves that 73% of consumers prefer brands that are sustainable, honest, and transparent about how and where products were raised or grown. Sustainable production is also high on their wishlist, with them being willing to pay a huge premium - anywhere from 30% to 40% on average – for sustainably produced goods. “Farm to Plate will be revolutionary for food brands looking to develop a strong identity with the sustainability-focused modern consumer. By enabling transparency and the ability to directly connect to their suppliers, brands can project a strong image as a modern, conscious corporation to their customers. This is the beginning of a long journey of trust between consumers and food brands.”- Mika Liss, Strategic Advisor, Farm To Plate.
Farm to Plate Fills the Missing Links in the Supply Chain
Food brands are struggling with the weight of regulatory requirements and the consumers’ transparency demands. Providing such in-depth and reliable information in a complex global supply chain poses challenges. There is heavy dependency on manual processes making data vulnerable to fraud and preventing timely information from passing to all stakeholders. Farm to Plate uses permissioned blockchain, AI-driven tools, and automation through IoT devices to provide access-controlled, immutable, real-time data to the right stakeholders. “We’ve built F2P with open, industry-standard technology that integrates seamlessly with your existing systems. And the best part about it is, it’s modular, allowing us to extend its capabilities almost infinitely as we build out features in future releases.”- Saptarshi Choudhury, VP of Product at Farm To Plate.
Connecting Consumers and Farmers for Sustainable Ecosystems
Through innovative use of popular messaging platforms such as WhatsApp, voice transcription, vernacular language translations and offline functionality, Farm To Plate is the first track and trace solution truly accessible to the fisherman and farmer. Through microtipping, Farm to Plate will leverage the consumer-farmer connection to bring financial stability to the producer community and reduce the risk of overfarming.
“Farm To Plate is the first food supply chain solution that will connect every stakeholder to the other, and make them part of the system. Uniquely, we connect consumers and farmers directly - enabling consumer food trust through transparency and financial sustainability for producers through a single QR code. Our value proposition is enshrined in the 5 Ts: Trace, Track, Trade, Tip, Trust – and Tip is our favorite because it acknowledges the farmer.”- Pramod Sajja, President and CEO, Farm to Plate LLC. & Paramount Software Solutions Inc.
About Farm to Plate
The vision of the Blockchain team of Farm to Plate was to develop a product to transform the way the food and beverage industry operates. The success stories of Hyperledger Fabric resulted in its adoption to enable bringing the open-source ecosystem to the forefront of this technology. Farm to Plate wanted to build something that made a difference, and yet simple to adapt to fill the gaps in the existing food supply chain systems.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230228006317/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Enginzyme and AGC Create Scalable Process for Key mRNA Ingredient12.1.2026 06:00:00 CET | Press release
At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹ΨTP). The rapid growth of mRNA-based vaccines and therapeutics has driven significant demand for modified nucleotides like m¹ΨTP, which enhances mRNA stability and expression, while reducing immunogenicity. Enginzyme is a deep-tech company delivering optimized biomanufacturing solutions through cell-free enzyme engineering technology. AGC Inc. is a leading global player in fields spanning from architectural glass to chemicals and life science. AGC Inc. provides services in a wide range of life science fields, from synthetic pharmaceuticals and agrochemicals, to biopharmaceuticals and leading-edge cell and gene therapies, as well as messenger RNAs. The presentation in November detailed the latest collaboration between the companies, with a focus on the biomanufacturing of nucleotides for mRNA therapy,
Ant International Partners with Google’s Universal Commerce Protocol to Expand AI Capabilities12.1.2026 02:15:00 CET | Press release
Ant International, a leading global payment, digitisation, and financial technology provider, is collaborating on the launch of Google’s Universal Commerce Protocol (UCP), a new open standard for agentic commerce that works across the entire shopping journey — from discovery and buying to post-purchase support. UCP establishes a common language for agents and systems to operate together across consumer surfaces, businesses, and payment providers to enable commerce. So instead of requiring unique connections for every individual agent, UCP enables all agents to interact easily. UCP is built to work across verticals and is compatible with existing industry protocols like Agent2Agent (A2A), Agent Payments Protocol (AP2), and Model Context Protocol (MCP). “For agentic commerce to scale, it’s critical for the industry to align on a common set of standards. We are proud to have Ant International endorse the Universal Commerce Protocol as the foundation for that future,” said Ashish Gupta, VP
Torq Secures $140M Series D at $1.2B Valuation to Lead the AI SOC and Agentic AI Era11.1.2026 17:59:00 CET | Press release
Fueled by Massive Customer Adoption of AI Agents, Torq Scales the World’s First True AI SOC Platform and Accelerates Expansion into the U.S. Federal Market Torq, the established Agentic AI security operations pioneer, today announced it has closed a massive $140 million Series D funding round, propelling its valuation to $1.2 billion and total funding to $332M. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112510774/en/ Led by Merlin Ventures—a leading cybersecurity fund renowned for its deep access to the U.S. commercial and Public Sector markets—with participation from all existing investors, including Evolution Equity Partners, Notable Capital, Bessemer Venture Partners, Insight Ventures Partners, and Greenfield Partners, this capital injection is a definitive investment in the future of security. Torq is driving the industry’s critical shift: the complete transformation of the Security Operations Center (SOC) through
Andersen udvider sine kompetencer med tilføjelsen af Scimitar9.1.2026 21:44:00 CET | Pressemeddelelse
Andersen Consulting har indgået en samarbejdsaftale med Scimitar, der er et firma med fokus på at accelerere innovation i biovidenskabsbranchen. Scimitar, der har hovedkvarter i USA, et førende konsulenthus inden for strategieksekvering for biovidenskabsbranchen. Virksomheden er specialiseret i design af driftsmodeller, digital transformation og organisatorisk forandring. Scimitar samarbejder med medicinal- og biotech-virksomheder om at accelerere innovation, styrke den driftsmæssige eksekvering og sikre compliance gennem hele produkters livscyklus. Deres praktiske og samarbejdsorienterede tilgang sikrer løsninger, der ikke blot er formålstjenlige, men også skalerbare. "Virksomheder inden for biovidenskabsbranchen befinder sig i en tid med hurtige videnskabelige fremskridt, stigende regulatorisk kompleksitet og et voksende behov for operationel agilitet, samtidig med at de holdes op mod de højeste standarder for patientsikkerhed og dataintegritet," udtaler Ramy Khalil, CEO i Scimitar.
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release
Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
